NANT Pancreatic Cancer Vaccine NantCell, Inc. Clinical Trial Protocol: QUILT -3.039 NANT PANCREATIC CANCER VACCINE : COMBINATION IMMUNOTHERAPY IN SUBJECTS WITH PANCREATIC CANCER WHO HAVE PROGRESSED ON OR AFTER STANDARD-OF -CARE THERAPY Study Number: QUILT -3.039 IND Sponsor: NantCell, Inc. 9920 Jefferson Blvd Culver City, CA 90232 Sponsor Contact: (For medical questions/emergencies) John H.